HKD
AMTD Digital Inc - ADR
-24.37%
$9.48 - $7.17
Feb 8th 2023 - Mar 22nd 2023
Mar, 20, 2023
$HKD: The Revenue has been growing by 138.30% on a... See more
Mar, 17, 2023
$HKD: The Revenue has been growing by 138.30% on a... See more
XERS
Xeris Biopharma Holdings Inc
15.52%
$1.16 - $1.34
Feb 7th 2023 - Mar 21st 2023
Mar, 17, 2023
Two other drugs, each growing revenue steadily.
Mar, 13, 2023
That said, I fully expect continuing script and r... See more
Divihomes is Now Live
A new search platform that matches you with the best home improvement service providers in your area.
Instant Search & Match with Top Contractors
Instant Communication with Local Contractors
Millions of Unbiased User Reviews
100% Free Quotes from Top-Notch Contractors
Mar, 20, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 17, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 14, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 13, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 9, 2023
$HKD shows a strong growth in Revenue.
Mar, 9, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Mar, 8, 2023
So many avenues for revenue with HKD.
Mar, 2, 2023
$HKD: The Revenue has been growing by 138.30% on average over the past 5 years.
Feb, 23, 2023
$HKD it's pretty simple, no debt, crazy amount of cash, huge increase first six months revenue and way undervalued.
Feb, 23, 2023
No debt, ridiculous balance sheet and 98 percent profit margins + 130 Percent Revenue Growth.
Mar, 17, 2023
Two other drugs, each growing revenue steadily.
Mar, 13, 2023
That said, I fully expect continuing script and revenue growth, upcoming cashflow breakeven and some nice juicy licensing deals to resolve that in the months ahead.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Mar, 3, 2023
Two (2) other drugs, each growing revenue steadily.
Feb, 24, 2023
There is so much good news here, growing revenue, a stable base, conservative management, and connections to big pharma.
Mar, 21, 2023
$FSR shows a strong growth in Revenue.
Mar, 21, 2023
Close to generating revenue is only positive
Mar, 21, 2023
$FSR Easy buy before revenue.
Mar, 20, 2023
$FSR shows a strong growth in Revenue.
Mar, 20, 2023
Looking at the last year, $FSR shows a very strong growth in Revenue.
Mar, 20, 2023
Looking at the last year, $FSR shows a very strong growth in Revenue.
Mar, 19, 2023
Revenue is expected to show an annual growth rate (CAGR 2023-2027) of 17.02%, resulting in a projected market volume of US$858.00bn by 2027. 🔥🍺
Mar, 18, 2023
$FSR: The Revenue has grown by 232.04% in the past year.
Mar, 18, 2023
$FSR: The Revenue has grown by 232.04% in the past year.
Mar, 17, 2023
Revenue and a profitable ocean program is coming.